InvestorsHub Logo
icon url

jessellivermore

04/30/20 7:06 AM

#270311 RE: FesteringPus #270301

From the Amarin release...

Quote: "Furthermore, the label being sought for VASCEPA in many of these geographies are not for the triglyceride reduction indication at issue in this patient litigation in the United States."

This is a big deal...They (the generics) don't have the MARINE indication to shoehorn in..

":>) JL